The underlying cause of lobar intracerebral hemorrhage (ICH) is often difficult to determine, since these vascular abnormalities are not necessarily visualized in radiographic studies. Wesought to determine the clinical features of hypertensive and non- (Internal Medicine 42: 576-580, 2003) 
hypertensive lobar ICH, and further predict the presence or absence of vascular abnormalities in terms of clinical features and radiographic abnormalities. Patients and Methods Eighty-one patients with lobar ICH were retrospectively assigned to either hypertensive or non-hypertensive groups based on their blood pressure levels during the chronic phase or a history of antihypertensive medication. The clinical and radiographic features of these two groups were compared.
Results Forty-nine patients (60%) were hypertensive, and the other thirty-two (40%) were non-hypertensive.
In the non-hypertensive group, amyloid angiopathy (n= 6), aneurysms (n=5), arteriovenous malformation (n=4), use of anticoagulants (n=2), liver cirrhosis (n=2) and thrombasthenia (n=l) were found as underlying causes.
There were no significant differences between these two groups in the frequencies of stroke risk factors except for hypertension, clinical features and initial neurological findings. On the contrary, subarachnoid extension of the hematomaon CT was significantly more frequent in the non-hypertensive lobar ICH group than in the hypertensive group (p<0.001). The patients with subarachnoid extension were morelikely to have vascular abnormality than those without subarachnoid extension (p<0.01). Conclusion Subarachnoid extension of the hematoma on CTstrongly indicates a non-hypertensive cause, and more specifically, it suggests lobar ICH caused by vascular abnormalities.
Introduction
Hypertension is a relatively infrequent cause of lobar intracerebral hemorrhage (ICH), compared to ICH in the deep regions such as the putamen, thalamus, cerebellum and pons (1) . Indeed, lobar ICH is the result of other heterogeneous causes, including arteriovenous malformation, cavernous angioma, aneurysm, brain tumors, especially those of metastatic origin (2, 3) , the use of anticoagulant or fibrinolytic agents, cerebral amyloid angiopathy and vasculitis (2) . Furthermore, the frequency of lobar ICH complicated by amphetamines (4), pseudoephedrine (5) , and cocaine (6) has increased recently. Other relatively rare causes may include moyamoya disease (7) , disseminated intravascular coagulation or sepsis (8) , cerebral venous thrombosis (9) and leptomeningeal anastomosis after the occlusion of major cerebral artery (10).
Lobar ICHis not necessarily rare, however, there are relatively few studies on lobar ICH in comparison with deep ICH in the thalamus, putamen, pons or cerebellum. In addition, it is often difficult to determine the underlying causes, since vascular abnormalities such as arteriovenous malformation, cavernous angiomaor aneurysmare not necessarily visualized in radiological studies. In the present study, we compared the clinical features of hypertensive and nonhypertensive lobar ICH, and further sought to predict the presence or absence of vascular abnormalities in terms of clinical features and CT findings of hematomas.
Lobar Cerebral Hemorrhage

Materials and Methods
Weretrospectively reviewed the records of 409 patients with ICHwhohad been admitted to our stroke care unit from January 1, 1985 to December 31, 1996. Among these patients, 81 were diagnosed with lobar ICH based on their CT findings. They consisted of 56 men and 25 women, and their mean age was 63±13 years (mean±SD). Cerebral angiographic studies were performed in 52 patients. Magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) were performed in 76 patients and CT angiography (CTA) was performed in 9 patients. These patients were classified into two groups based on the presence or absence of hypertension in the chronic phase. Hypertension was defined to be present if patients fulfilled at least one of the following criteria: 1) a history of antihypertensive medication, 2) a history of hypertension diagnosed by a referring physician or 3) systolic blood pressure greater than 160 mmHg or diastolic blood pressure greater than 95 mmHg on two or more discrete occasions, after 1 month has lapsed from the onset of the ICH. We then investigated the differences in clinical and radiographic features between the hypertensive and nonhypertensive lobar ICH patients. The variables analyzed included 1) age and gender; 2) probable pathogenesis; 3) location of the hematoma; 4) stroke risk factors including diabetes mellitus, hyperlipidemia, habits of smoking and alcoholic beverage, prior symptomatic stroke or transient ischemic attacks, ischemic heart diseases (myocardial infarction or angina) and hepatic diseases; 5) clinical features at onset such as severe headache, convulsions, vomiting, vertigo or dizziness; 6) initial neurological findings such as the level of consciousness (alert, lethargic, stupor, coma), motor and sensory deficits, dysarthria and aphasia; 7) laboratory findings including fasting blood sugar, hematocrit, platelets, total cholesterol, triglyceride, hemoglobin Al e, prothrombin time, activated partial thromboplastin time, fibrinogen, and fibrin/fibrinogen degradation products; 8) initial CT findings such as hematoma volume (cm3), ventricular enlargement, mass effect (shift of midline structures or any evidence of herniation) and hematoma extension to the ventricles or subarachnoid space; 9) the duration of admission; and 10) the clinical outcome (modified Rankin scale) (1 1). The volume of the ICH was determined in the following manner (12, 13) . On the CT slice which shared the largest area of ICH, the largest diameter (A) of the hematoma was measured in centimeters. The second diameter (B) was represented by a line perpendicular to the largest diameter. The height of the hematomawas then calculated by multiplying the numberof slices and the slice thickness, thus providing the third diameter (C). These three diameters were multiplied and then divided by 2 (AxBxC/2) to obtain the volume of the ICH. Weused the %2test and Student's t test for group comparisons. P values of 0.05 or less were considered to be statistically significant. Hematomaswere distributed more commonlyin the anterior regions than in the posterior regions in both groups ( Table 2 ). There were no significant differences between the two groups in terms of stroke risk factors, clinical features at onset, initial neurologic findings and clinical outcome. Laboratory examination also revealed no significant differences between the two groups (Table 3 ). In the initial CT findings, there were no significant differences in hematomavolume or in the frequency of ventricular enlargement, mass effect and ventricular extension between the two groups. However, subarachnoid extension was significantly more frequent in the non-hypertensive group (1 1 out of 32, 34.4%) than in the hypertensive group (2 out of 49, 4.1%) ( Table 4 ). Figures 1A and IB show representative CT findings of lobar ICH with and without subarachnoid extension, respectively. Of 13 patients with subarachnoid extension, 2 were hypertensive patients and ll were nonhypertensive patients. In the later, 6 had vascular abnormality (2 with cerebral amyloid angiopathy, 2 with aneurysm and 2 with arteriovenous malformation ( Table 5 ). On the other hand, of 68 patients without subarachnoid extension, only 9 patients had vascular abnormality. These results indicate that patients with subarachnoid extension are more likely to have vascular abnormality than those without subarachnoid extension (p<0.001).
Results
Discussion
The frequency of hypertension among patients with lobar ICH was reported to range from 20.0% to 47.5% in the 1980's ( Table 6 ) (1, (15) (16) (17) (18) . The frequency of hypertension in lobar ICH (60.0%) in the present study was higher than previously reported. A similarly high frequency of hypertension was reported in the 1990's by Massaro et al (54.8%) (19) and by Broderick et al (67.0%) (20) . These reports pointed out the importance of hypertension as a cause of lobar ICH, and may indicate an increasing trend towards hypertensive lobar ICH, which has become noteworthy in the 1990's (19, 20) .
Previous studies have reported the preferential localization of lobar ICH in specific sites in the brain. The most frequent site was the parietal lobe as reported by Weisberg (16) , the occipital lobe by Ropper and Davis (15) , the temporoparietal lobes by Kase et al (1) , and the temporal or temporoparietal lobes by Tanaka et al (17) . In the study by Massaro et al, lobar ICHconfined to one lobe was observed most frequently in the frontal lobe. Lobar ICH overlying two or more lobes was located predominantly in the parieto-temporal or parieto-occipital lobes (19) . In the present study, the frontal lobe was most commonly affected regardless of the presence or absence of hypertension. Morethan half of the patients with hypertensive lobar ICH had a frontal or temporal lesion, and patients with non-hypertensive lobar ICHshowed a preferential localization in the frontal lobe. These results may simply reflect the fact that the frontal lobe has the largest volume of all lobes. Taken together, it is likely that there are no specific lobes which are particularly susceptible to lobar (Table 4 ). Since subarachnoid extension was observed in non-hypertensive ICH patients, one half of the patients was expected to have vascular abnormalities ( Table 5 ). Wakai et al examined brain specimens with lobar ICH but without angiographic abnormalities, and found vascular abnormalities such as amyloid angiopathy or vascular malformations in all patients with subarachnoid extension (24) . Cerebral amyloid angiopathy occurs almost exclusively in the cerebral cortex (25, 26) , and this may also help to explain the association of subarachnoid extension with non- hypertensive ICH. Taken together, it is highly likely that subarachnoid extension is characteristic of lobar ICHcaused by vascular abnormalities. It seems reasonable to assume that hypertensive lobar ICH is caused more often by hypertension per se than by vascular or coagulation abnormalities. However,subarachnoid extension in hypertensive lobar ICHpatients also warrants an extensive search for the underlying causes, because vascular or coagulation abnormalities may coexist with hypertension. Furthermore, recent advances in molecular biology have demonstrated an association between genetic abnormalities and some types of cerebrovascular disease. ICH is occasionally found in hereditary hemorrhagic telangiectasia, hereditary cerebral cavernous malformation with genetic heterogeneity mappedto 7q22, and hereditary cerebral amyloid angiopathy of either Dutch or Icelandic type (27) . These abnormalities should be further investigated in non-hypertensive lobar ICH patients.
